331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster I

Association between Extracellular Vesicles (EVs) and Thrombosis in Antiphospholipid Syndrome

Clinical and Serological Characteristics of Vaccine-Associated Immune Thrombocytopenia Following COVID-19 Vaccination

Impact of Timing of Acute Graft-Versus-Host-Disease on Incidence of Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation

Patient Reported Outcomes during Long-Term Follow-up of Atypical Hemolytic Uremic Syndrome in the Era of Terminal Complement Inhibition

Real World Data on the Utility of P-Selectin Expression Assay; Correlation of Test Results and Disease Expression

Risk Factors for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation By Disease Groups in Competing Risk Analysis

Ticagrelor Interference in the Serotonin-Release Assay